Anderson, T.J., Ferguson, D.J.P., Raab, G.M.Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and lateralityBr J Cancer1982; 46: 376-82.
2.
Brinton, L.A., Hoover, R., Szklo, M., Fraumeni, J.F.Oral contraceptives and breast cancerInt J Cancer1982;11: 316-22.
3.
Centers for Disease Control.Cancer and steroid hormone study. Long term oral contraceptive use and the risk of breast cancerJAMA1983; 249: 1591-5.
4.
Cook, P.J., Doll, R., Fellingham, S.A.A mathematical model for the age distribution of cancer in manIntJ Cancer1969; 4 : 93-112.
5.
Cutler, S.J., Young, J.L.Third National Cancer Survey: Incidence DataNat Cancer Inst Monog.1975 ; 41 .
6.
De Waard, F., Cornelis, J.P., Aoki, K., Yoshida, M.Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi Prefecture, Japan.Cancer1977; 40: 1269-75.
7.
Dulbecco, R., Henahan, M., Armstrong, B.Cell types and morphogenesis in the mammary glandProc Natl Acad Sci USA1982; 79 : 7346-50.
8.
Ferguson, D.J.P., Anderson, T.J.Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breastBr J Cancer1981; 44: 177-81.
9.
Henderson, B.E., Powell, D., Rosario, 1., Keys, C., Hanisch, R., Young, M., Casagrande, J., Gerkins, V., Pike, M.C.An epidemiologic study of breast cancerJ Natl Cancer Inst.1974; 53: 609-14.
10.
Henderson, B.E., Gerkins, V., Rosario, I., Casagrande, J.T., Pike, M.C.Elevated serum levels of estrogen and prolactin in daughters of patients, with breast cancerN Engl J Med.1975 : 293: 790-5.
11.
Henderson, B.E., Pike, M.C., Casagrande, J.T.Breast cancer and the oestrogen window hypothesisLancet1981; ii: 363.
12.
Henderson, B.E., Casagrande, J.T., Pike, M.C., Mack, T., Rosario, I., Duke, A.The epidemiology of endometrial cancer in young womenBr J Cancer1983; 47 : 749-56.
13.
Hennekens, C.H., Speizer, F.E., Lipnick, R.J., Rosner, B., Bain, C., Belanger, C., Stampfer, M.J., Willett, W., Peto, R.A case-control study of oral contraceptive use and breast cancerJ Natl Cancer Inst.1984; 72: 39-42.
14.
Jick, H., Walker, A.M., Watkins, R.N., D'Ewart, D.C., Hunter, J.R., Danford, A., Madsen, S., Dinan, B.J., Rothman, K.J.Oral contraceptives and breast cancerAm J Epidemiol . 1980;112: 577-85.
15.
Kalache, A., Mcpherson, K., Barltrop, K., Vessey, M.P.Oral contraceptives and breast cancerBrJ Hosp Med.1983; 28: 278-83.
16.
Kwa, H.G., Cleton, F., Bulbrook, R.D., Wang, D.Y., Hayward, J.L.Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birthInt J Cancer1981; 28: 31-4.
17.
Lew, E.A., Garfinkel, L.Variations in mortality by weight among 750,000 men and womenJ Chron Dis.1979; 32 : 563-576.
18.
Macmahon, B., Cole, P., Lin, T.M., Lowe, C.R., Mirra, A.P., Ravnihar, B., Salber, E.J., Valaoras, V.G., Yuasa, S.Age at first birth and breast cancer riskBull WHO1970; 43: 209-17.
19.
Macmahon, B., Trichopoulos, D., Brown, J., Anderson, A.P., Aoki, K., Cole, P., De Waard, F., Kauraniemi, T., Morgan, R.W., Purde, M., Ravnihar, B., Stormby, N., Westlund, K., Woo, N-C.Age at menarche, probability of ovulation and breast cancer riskInt J Cancer1982; 29 : 13-6.
20.
Mcpherson, K., Neil, A., Vessey, M.P., Doll, R.Oral contraceptives and breast cancerLancet1983; ii: 1414-5.
21.
Olsson, H., Landin-Olsson, M., Gullberg, B.Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast diseaseJ Natl Cancer Inst.1983; 70: 17-20.
22.
Paffenbarger, R.S., Kampert, J.B., Chang, H.Oral contraceptives and breast cancer riskInserm1979; 83: 93-8.
23.
Pike, M.C., Gerkins, V.R., Casagrande, J.T., Gray, G.E., Brown, J., Henderson, B.E.The hormonal basis of breast cancerNatl Cancer Inst Monog.1979; 53: 187-93.
24.
Pike, M.C., Henderson, B.E., Casagrande, J.T., Rosario, I., Gray, G.E.Oral contraceptive use and early abortion as risk factors for breast cancer in young womenBr J Cancer1981 ; 43: 72-76.
25.
Pike, M.B., Henderson, B.E., Krailo, M.D., Duke, A.Roy, S.Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at useLancet1983a; ii: 926-30.
26.
Pike, M.C., Krailo, M.D., Henderson, B.E., Casagrande, J.T., Hoel, D.G.'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancerNature1983;b 303: 767-70.
27.
Royal College Of General Practitioners.Breast cancer and oral contraceptives: findings in Royal College of General Practitioners' StudyBr Med J.1981; i: 2089-93.
28.
Siiteri, P.K., Hammond, G.L., Nisker, J.A.Increased availability of serum estrogens in breast cancer: a new hypothesis In Banbury Report 8: Hormones and Breast Cancer. (Eds: Pike, M. C., Sitteri, P. K., Welsch, C. W.). Cold Spring Harbor Laboratory, New York , 1981.
29.
Trichopoulos, D., Macmahon, B., Cole, P.Menopause and breast cancer riskJ Natl Cancer Inst.1972; 48: 605-13.
30.
Vessey, M.P., Mcpherson, K., Doll, R.Breast cancer and oral contraceptives: findings in Oxford — Family Planning Association contraceptive studyBr Med J.1981; i: 2093-4.
31.
Vessey, M.P., Mcpherson, K., Yeates, D., Doll, R.Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer riskBr J Cancer1982; 45: 327-31.
32.
Vessey, M.P., Baron, J., Doll, R., Mcpherson, K., Yeates, D.Oral contraceptives and breast cancer: final report of an epidemiological studyBrJ Cancer1983; 47: 455-62.
33.
Wallace, R.B., Sherman, B., Bean, J.A., Leeper, J.P., Treloar A.E.Menstrual cycle patterns and breast cancer risk factorsCancer Res.1978; 38 : 4021-4.
